Figure 3.
Antibiotics given to patients pre-aHSCT worsen overall survival. (A) Survival analysis by Kaplan–Meier curves of all aHSCT patients either in the ATB or no ATB group. Day 0 was the day of stem cell infusion. The OS was reduced in patient receiving ATB before their transplant at 1 y, 2 y, and 10 y. (B) Survival analysis by Kaplan–Meier cruves of patients that undergone a myeloablative aHSCT and either received or not ATB before the transplant. OS was reduced in the ATB group at 1 y and 2 y. Log-rank (Mantel–Cox); *p < 0.05, **p < 0.01,***p < 0.001, ns = not significant.